ZA882391B - Controlling the growth of tumor tissue with chalcone derivatives - Google Patents

Controlling the growth of tumor tissue with chalcone derivatives

Info

Publication number
ZA882391B
ZA882391B ZA882391A ZA882391A ZA882391B ZA 882391 B ZA882391 B ZA 882391B ZA 882391 A ZA882391 A ZA 882391A ZA 882391 A ZA882391 A ZA 882391A ZA 882391 B ZA882391 B ZA 882391B
Authority
ZA
South Africa
Prior art keywords
growth
tumor tissue
controlling
chalcone derivatives
agents
Prior art date
Application number
ZA882391A
Other languages
English (en)
Inventor
L. Edwards Michael
M. Stemerick David
P. Sunkara Sai
Original Assignee
Merrell Dow Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc. filed Critical Merrell Dow Pharmaceuticals Inc.
Publication of ZA882391B publication Critical patent/ZA882391B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA882391A 1987-04-09 1988-04-05 Controlling the growth of tumor tissue with chalcone derivatives ZA882391B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/036,227 US4904697A (en) 1987-04-09 1987-04-09 Controlling the growth of certain tumor tissue with chalcone derivatives

Publications (1)

Publication Number Publication Date
ZA882391B true ZA882391B (en) 1988-09-23

Family

ID=21887400

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA882391A ZA882391B (en) 1987-04-09 1988-04-05 Controlling the growth of tumor tissue with chalcone derivatives

Country Status (8)

Country Link
US (1) US4904697A (xx)
EP (1) EP0288794B1 (xx)
KR (1) KR880012217A (xx)
AT (1) ATE106723T1 (xx)
AU (1) AU599220B2 (xx)
DE (1) DE3889970T2 (xx)
PH (1) PH25183A (xx)
ZA (1) ZA882391B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753965A (en) * 1987-04-09 1988-06-28 Merrell Dow Pharmaceuticals, Inc. Method of treating multiple sclerosis with chalcone derivatives
AU634921B2 (en) * 1990-12-25 1993-03-04 Ohgen Research Laboratories Ltd. Deacetylcolchicine derivatives
AU2776892A (en) * 1991-10-07 1993-05-03 Cancer Immunology Research Corporation, The Treatment of premalignant and malignant lesions
US5681812A (en) * 1991-12-10 1997-10-28 Rush Presbyterian-St. Luke's Medical Center Methods and compositions for reducing multidrug resistance
AU3243393A (en) * 1991-12-10 1993-07-19 Rush - Presbyterian - St. Luke's Medical Center Methods and compositions for reducing multi-drug resistance
US5952355A (en) * 1993-11-17 1999-09-14 Kyowa Hakko Kogyo Co., Ltd. Propenone derivatives
IL112205A0 (en) * 1994-01-06 1995-03-15 Res Dev Foundation Curcumin, analogues of curcumin and novel uses thereof
GB9401891D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
US5834442A (en) * 1994-07-07 1998-11-10 Barbara Ann Karmanos Cancer Institute Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
EP0770601A4 (en) * 1995-05-10 1998-08-05 Kyowa Hakko Kogyo Kk PROPENONE DERIVATIVES
IL121789A (en) * 1996-10-03 2001-06-14 Rohm & Haas A medicinal product for inhibiting mammalian cell tumors
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
AU771994B2 (en) * 1996-12-02 2004-04-08 Ipxmedical, Llc Compositions and methods for treating or preventing inflammatory diseases
AU2004200715B2 (en) * 1996-12-02 2006-08-31 Angiotech International Ag Compositions and methods for treating or preventing inflammatory diseases
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
EP0947511A1 (en) * 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity
EP0947494A1 (en) * 1998-03-30 1999-10-06 F. Hoffmann-La Roche Ag Derivatives of phenoxy acetic acid and phenoxymethyltetrazole having antitumor activity
CN1447804A (zh) 2000-06-20 2003-10-08 阿特罗吉尼克斯公司 1,3－二－(被取代的苯基)－2－丙烯－1－酮及其治疗vcam－1介导的疾病的用途
BR0115474A (pt) 2000-11-17 2006-01-31 Idenix Cayman Ltd Composição e método para inibição da transmissão de hiv que usam 6-benzil-4-oxopirimidinas substituìdas aplicada por via tópica
FR2817749A1 (fr) * 2000-12-13 2002-06-14 Aventis Pharma Sa Nouvelle utilisation des composes de la classe des chalcones
GB0126889D0 (en) * 2001-11-08 2002-01-02 Paterson Inst For Cancer Res Compounds and their uses
PE20030758A1 (es) * 2001-12-05 2003-10-07 Aventis Pharma Sa 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion
US20040147584A2 (en) * 2001-12-05 2004-07-29 Aventis Pharma S.A. 1,3-diarylprop-2-en-1-ones, compositions containing them and use thereof
FR2833008B1 (fr) * 2001-12-05 2004-05-21 Aventis Pharma Sa 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
FR2833004B1 (fr) * 2001-12-05 2004-12-10 Aventis Pharma Sa Aryl-cycloalcaines substitues, compositions les contenant et utilisation
TW200303302A (en) * 2001-12-19 2003-09-01 Atherogenics Inc Chalcone derivatives and their use to treat diseases
AU2002342808A1 (en) * 2002-10-09 2004-05-04 Unibioscreen S.A. Extract with anti-tumor and anti-poisonous activity
WO2004056727A2 (en) * 2002-12-19 2004-07-08 Atherogenics, Inc. Process of making chalcone derivatives
US7326734B2 (en) * 2003-04-01 2008-02-05 The Regents Of The University Of California Treatment of bladder and urinary tract cancers
US20050249667A1 (en) * 2004-03-24 2005-11-10 Tuszynski Jack A Process for treating a biological organism
WO2006004903A2 (en) * 2004-06-28 2006-01-12 Atherogenics, Inc. 1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
EP3200794A4 (en) 2014-09-29 2018-06-20 The Penn State Research Foundation A compound for anti-cancer therapy that acts by targeting gof mutant p53 and stimulates p73
US11746104B2 (en) 2019-06-13 2023-09-05 Qatar University Chalcone-based chemotherapeutic compound for triple negative breast cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL255071A (xx) * 1959-08-20
US3729313A (en) * 1971-12-06 1973-04-24 Minnesota Mining & Mfg Novel photosensitive systems comprising diaryliodonium compounds and their use
US3808006A (en) * 1971-12-06 1974-04-30 Minnesota Mining & Mfg Photosensitive material containing a diaryliodium compound, a sensitizer and a color former
DE2602419A1 (de) * 1976-01-23 1977-07-28 Basf Ag Photopolymerisierbare masse
JPS6026122B2 (ja) * 1977-01-20 1985-06-21 富士写真フイルム株式会社 光重合性組成物
US4162162A (en) * 1978-05-08 1979-07-24 E. I. Du Pont De Nemours And Company Derivatives of aryl ketones and p-dialkyl-aminoarylaldehydes as visible sensitizers of photopolymerizable compositions
JPS54152091A (en) * 1978-05-22 1979-11-29 Fuji Photo Film Co Ltd Photopolymerizable composition
US4279930A (en) * 1978-10-10 1981-07-21 The Upjohn Company Process for treating inflammation
NZ192641A (en) * 1979-01-26 1984-10-19 Hoffmann La Roche Substituted acetophenones and pharmaceutical compositions
EP0028305B1 (en) * 1979-09-13 1984-02-01 The Wellcome Foundation Limited Diaryl compounds and pharmaceutical formulations containing them
CA1168659A (fr) * 1980-08-06 1984-06-05 Gerard Lang Derives de dibenzoylmethane quaternaire, leur utilisation comme agent filtrant solaire et composition cosmetique les contenant
US4753965A (en) * 1987-04-09 1988-06-28 Merrell Dow Pharmaceuticals, Inc. Method of treating multiple sclerosis with chalcone derivatives

Also Published As

Publication number Publication date
EP0288794A2 (en) 1988-11-02
PH25183A (en) 1991-03-27
ATE106723T1 (de) 1994-06-15
US4904697A (en) 1990-02-27
DE3889970D1 (de) 1994-07-14
EP0288794B1 (en) 1994-06-08
AU1416488A (en) 1988-10-13
EP0288794A3 (en) 1988-11-23
KR880012217A (ko) 1988-11-26
AU599220B2 (en) 1990-07-12
DE3889970T2 (de) 1994-10-06

Similar Documents

Publication Publication Date Title
EP0288794A3 (en) Controlling the growth of tumor tissue with chalcone derivatives
AU1416688A (en) Method of treating multiple sclerosis with chalcone derivatives
AU574350B2 (en) Human nerve growth factor by recombinant technology
AU6998787A (en) Transglutaminase inhibitors
AU4250389A (en) Method for controlling the growth of non-osseous non-cartilaginous solid connective tissue
DE69434209D1 (de) REGULATION DER GENEXPRESSION VON bcl-2
AU2883689A (en) The use of moclobemide to treat or prevent cognitive disorders
DE3881775D1 (de) De-mannosylteicoplanin-derivate.
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
ATE90568T1 (de) Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
CA2071653A1 (en) Method of preparing activated protein c
DE69313316T2 (de) Verwendung von Oxazopyrrolochinolinen und Pyrrolochinolonchinonen zur Herstellung von Produktionsbeschleunigern von Nervenwachstumsfaktoren g
MY106615A (en) Stabilized leukocyte-interferons.
DE59100964D1 (de) Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen.
HUT47033A (en) Process for production of medical compositions against tumor
AU1416588A (en) Methods of treating gout with chalcone derivatives
AU3439889A (en) Improvements relating to the control of neoplastic tissue growth
IL89901A0 (en) Strobilurine derivatives
AU1496988A (en) Porcine growth hormone analogs
IE881077L (en) Controlling the growth of tumor tissue with chalcone¹derivatives
AU580646B2 (en) 13``-alkyl-17``-(3-aceloxy-propyl)-gonane
ATE69137T1 (de) Stabilisiertes gossyplure und verfahren zu dessen herstellung.